Literature DB >> 7922587

Expression of group II phospholipase A2 in rat brain after severe forebrain ischemia and in endotoxic shock.

I Lauritzen1, C Heurteaux, M Lazdunski.   

Abstract

Secretory phospholipase A2 type II is known to be involved in various inflammatory processes. This paper describes the changes in secretory phospholipase A2 (PLA2) gene expression induced by ischemia and endotoxic shock. Type I PLA2 (pancreatic type) is not expressed in ischemic and endotoxic-shock brains but both ischemia and endotoxin injection induce type II PLA2 expression. The first phase of PLA2 II gene expression following the ischemic insult occurs 1-6 h after ischemia. During that period, PLA2 II gene expression is slightly enhanced and it returns to control levels after 1 day. A second phase corresponding to higher levels of induction of mRNA for PLA2 appears at a later period after ischemia between 7 and 18 days. In situ hybridization shows that PLA2 gene expression in the ischemic brain is localized in regions known to be vulnerable to ischemia (hippocampus and neocortex). Endotoxic shock which leads to a major inflammatory state induces an abundant expression of the PLA2 II mRNA in the brain and this high level of expression appears in a large number of brain structures. The results suggest that the early phase of ischemia-induced PLA2 gene expression could be an additional element in mechanisms leading to neuronal death. The later phase of increased PLA2 mRNA levels is more probably related to the inflammatory response associated to neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7922587     DOI: 10.1016/0006-8993(94)90719-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

Review 2.  Phospholipases A2 in ischemic and toxic brain injury.

Authors:  A Sapirstein; J V Bonventre
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

Review 3.  Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists.

Authors:  Grace Y Sun; Jianfeng Xu; Michael D Jensen; Sue Yu; W Gibson Wood; Fernando A González; Agnes Simonyi; Albert Y Sun; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

4.  Secretory phospholipase A2 activity in the normal and kainate injected rat brain, and inhibition by a peptide derived from python serum.

Authors:  M-M Thwin; W-Y Ong; C-W Fong; K Sato; K Kodama; A A Farooqui; P Gopalakrishnakone
Journal:  Exp Brain Res       Date:  2003-04-18       Impact factor: 1.972

5.  Cortical impact injury in rats promotes a rapid and sustained increase in polyunsaturated free fatty acids and diacylglycerols.

Authors:  P Homayoun; N E Parkins; J Soblosky; M E Carey; E B Rodriguez de Turco; N G Bazan
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

Review 6.  Phospholipase A2-mediated hydrolysis of cardiac phospholipids: the use of molecular and transgenic techniques.

Authors:  L J De Windt; R S Reneman; G J Van der Vusse; M Van Bilsen
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 7.  Integration of cytokine biology and lipid metabolism in stroke.

Authors:  Rao Muralikrishna Adibhatla; Robert Dempsy; James Franklin Hatcher
Journal:  Front Biosci       Date:  2008-01-01

Review 8.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

9.  Acetate reduces PGE2 release and modulates phospholipase and cyclooxygenase levels in neuroglia stimulated with lipopolysaccharide.

Authors:  Mahmoud L Soliman; Joyce E Ohm; Thad A Rosenberger
Journal:  Lipids       Date:  2013-05-25       Impact factor: 1.880

10.  Opposite modulation of NMDA receptors by lysophospholipids and arachidonic acid: common features with mechanosensitivity.

Authors:  M Casado; P Ascher
Journal:  J Physiol       Date:  1998-12-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.